Cargando…

Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia

Object: To identify genes of prognostic value which associated with tumor microenvironment (TME) in acute myeloid leukemia (AML). Methods and Materials: Level 3 AML patients gene transcriptome profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Clinical characteristics and surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Jie, Wu, Yang, Qi, Feng, Li, Xiao, Yu, Shaorong, Liu, Siwen, Feng, Jifeng, Zheng, Yuxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990132/
https://www.ncbi.nlm.nih.gov/pubmed/32039005
http://dx.doi.org/10.3389/fonc.2019.01509
_version_ 1783492481071972352
author Ni, Jie
Wu, Yang
Qi, Feng
Li, Xiao
Yu, Shaorong
Liu, Siwen
Feng, Jifeng
Zheng, Yuxiao
author_facet Ni, Jie
Wu, Yang
Qi, Feng
Li, Xiao
Yu, Shaorong
Liu, Siwen
Feng, Jifeng
Zheng, Yuxiao
author_sort Ni, Jie
collection PubMed
description Object: To identify genes of prognostic value which associated with tumor microenvironment (TME) in acute myeloid leukemia (AML). Methods and Materials: Level 3 AML patients gene transcriptome profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Clinical characteristics and survival data were extracted from the Genomic Data Commons (GDC) tool. Then, limma package was utilized for normalization processing. ESTIMATE algorithm was used for calculating immune, stromal and ESTIMATE scores. We examined the distribution of these scores in Cancer and Acute Leukemia Group B (CALGB) cytogenetics risk category. Kaplan-Meier (K-M) curves were used to evaluate the relationship between immune scores, stromal scores, ESTIMATE scores and overall survival. We performed clustering analysis and screened differential expressed genes (DEGs) by using heatmaps, volcano plots and Venn plots. After pathway enrichment analysis and gene set enrichment analysis (GESA), protein-protein interaction (PPI) network was constructed and hub genes were screened. We explore the prognostic value of hub genes by calculating risk scores (RS) and processing survival analysis. Finally, we verified the expression level, association of overall survival and gene interactions of hub genes in the Vizome database. Results: We enrolled 173 AML samples from TCGA database in our study. Higher immune score was associated with higher risk rating in CALGB cytogenetics risk category (P = 0.0396) and worse overall survival outcomes (P = 0.0224). In Venn plots, 827 intersect genes were screened with differential analysis. Functional enrichment clustering analysis revealed a significant association between intersect genes and the immune response. After PPI network, 18 TME-related hub genes were identified. RS was calculated and the survival analysis results revealed that high RS was related with poor overall survival (P < 0.0001). Besides, the survival receiver operating characteristic curve (ROC) showed superior predictive accuracy (area under the curve = 0.725). Finally, the heatmap from Vizome database demonstrated that 18 hub genes showed high expression in patient samples. Conclusion: We identified 18 TME-related genes which significantly associated with overall survival in AML patients from TCGA database.
format Online
Article
Text
id pubmed-6990132
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69901322020-02-07 Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia Ni, Jie Wu, Yang Qi, Feng Li, Xiao Yu, Shaorong Liu, Siwen Feng, Jifeng Zheng, Yuxiao Front Oncol Oncology Object: To identify genes of prognostic value which associated with tumor microenvironment (TME) in acute myeloid leukemia (AML). Methods and Materials: Level 3 AML patients gene transcriptome profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Clinical characteristics and survival data were extracted from the Genomic Data Commons (GDC) tool. Then, limma package was utilized for normalization processing. ESTIMATE algorithm was used for calculating immune, stromal and ESTIMATE scores. We examined the distribution of these scores in Cancer and Acute Leukemia Group B (CALGB) cytogenetics risk category. Kaplan-Meier (K-M) curves were used to evaluate the relationship between immune scores, stromal scores, ESTIMATE scores and overall survival. We performed clustering analysis and screened differential expressed genes (DEGs) by using heatmaps, volcano plots and Venn plots. After pathway enrichment analysis and gene set enrichment analysis (GESA), protein-protein interaction (PPI) network was constructed and hub genes were screened. We explore the prognostic value of hub genes by calculating risk scores (RS) and processing survival analysis. Finally, we verified the expression level, association of overall survival and gene interactions of hub genes in the Vizome database. Results: We enrolled 173 AML samples from TCGA database in our study. Higher immune score was associated with higher risk rating in CALGB cytogenetics risk category (P = 0.0396) and worse overall survival outcomes (P = 0.0224). In Venn plots, 827 intersect genes were screened with differential analysis. Functional enrichment clustering analysis revealed a significant association between intersect genes and the immune response. After PPI network, 18 TME-related hub genes were identified. RS was calculated and the survival analysis results revealed that high RS was related with poor overall survival (P < 0.0001). Besides, the survival receiver operating characteristic curve (ROC) showed superior predictive accuracy (area under the curve = 0.725). Finally, the heatmap from Vizome database demonstrated that 18 hub genes showed high expression in patient samples. Conclusion: We identified 18 TME-related genes which significantly associated with overall survival in AML patients from TCGA database. Frontiers Media S.A. 2020-01-21 /pmc/articles/PMC6990132/ /pubmed/32039005 http://dx.doi.org/10.3389/fonc.2019.01509 Text en Copyright © 2020 Ni, Wu, Qi, Li, Yu, Liu, Feng and Zheng. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ni, Jie
Wu, Yang
Qi, Feng
Li, Xiao
Yu, Shaorong
Liu, Siwen
Feng, Jifeng
Zheng, Yuxiao
Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
title Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
title_full Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
title_fullStr Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
title_full_unstemmed Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
title_short Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
title_sort screening the cancer genome atlas database for genes of prognostic value in acute myeloid leukemia
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990132/
https://www.ncbi.nlm.nih.gov/pubmed/32039005
http://dx.doi.org/10.3389/fonc.2019.01509
work_keys_str_mv AT nijie screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia
AT wuyang screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia
AT qifeng screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia
AT lixiao screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia
AT yushaorong screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia
AT liusiwen screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia
AT fengjifeng screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia
AT zhengyuxiao screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia